Peca Labs Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$12.8M
- Investors
-
10
Peca Labs General Information
Description
Developer of polymer-based cardiovascular implants designed to improve the treatment of cardiac defects. The company offers polymeric heart valves and vascular grafts with a valved shunt for hypoplastic left heart syndrome, enabling pediatric surgeons to reduce the need for repeated open-heart procedures in children over time.
Contact Information
Website
www.pecalabs.comCorporate Office
- 4424 Penn Avenue
- Suite 201
- Pittsburgh, PA 15224
- United States
Corporate Office
- 4424 Penn Avenue
- Suite 201
- Pittsburgh, PA 15224
- United States
Peca Labs Timeline
Peca Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series B) | 09-Oct-2026 | $12.8M | Completed | Generating Revenue | ||
| 14. Later Stage VC (Series A) | 20-Nov-2025 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series A) | 27-Dec-2024 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series A) | 15-Sep-2021 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series A) | 05-Jun-2020 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 04-Feb-2019 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 8. Grant | 26-Sep-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 05-Feb-2018 | $1.41M | $5.01M | Completed | Generating Revenue | |
| 6. Grant | 01-Jan-2017 | $149K | $3.6M | Completed | Startup |
Peca Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A10 | ||||||||
| Series A9 | ||||||||
| Series A8 | ||||||||
| Series A7 | ||||||||
| Series A6 | ||||||||
| Series A5 | ||||||||
| Series A4 | 75,676 | $0.000100 | 8% | $18.5 | $18.5 | 1x | $18.5 | 2.76% |
| Series A3 | 12,370 | $0.000100 | 8% | $12.01 | $12.01 | 1x | $12.01 | 0.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Peca Labs Comparisons
Industry
Financing
Details
Peca Labs Competitors (4)
One of Peca Labs’s 4 competitors is Xeltis, a Venture Capital-Backed company based in Eindhoven, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xeltis | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| PUR Biologics | Failed Transaction (M&A) | Irvine, CA | ||||
| Corvivo | Private Equity-Backed | Roswell, GA | ||||
| Medtronic | Corporation | Minneapolis, MN |
Peca Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Peca Labs Patents
Peca Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025251026-A1 | Polymer materials with medical applications and methods for manufacturing | Pending | 31-May-2024 | ||
| EP-3522830-A1 | Transcatheter stent and valve assembly | Active | 10-Oct-2016 | ||
| EP-3522830-A4 | Transcatheter stent and valve assembly | Active | 10-Oct-2016 | ||
| EP-3522830-B1 | Transcatheter stent and valve assembly | Active | 10-Oct-2016 | ||
| EP-3522830-C0 | Transcatheter stent and valve assembly | Active | 10-Oct-2016 | A61F2/2418 |
Peca Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Peca Labs Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Runway Healthcare | Venture Capital | Minority | ||
| Allegheny Financial Group | Asset Manager | Minority | ||
| Warren Point Capital | Venture Capital | Minority | ||
| Mountain State Capital | Venture Capital | Minority | ||
| Children's National | Corporation |
Peca Labs FAQs
-
When was Peca Labs founded?
Peca Labs was founded in 2012.
-
Where is Peca Labs headquartered?
Peca Labs is headquartered in Pittsburgh, PA.
-
What is the size of Peca Labs?
Peca Labs has 30 total employees.
-
What industry is Peca Labs in?
Peca Labs’s primary industry is Therapeutic Devices.
-
Is Peca Labs a private or public company?
Peca Labs is a Private company.
-
What is the current valuation of Peca Labs?
The current valuation of Peca Labs is .
-
What is Peca Labs’s current revenue?
The current revenue for Peca Labs is .
-
How much funding has Peca Labs raised over time?
Peca Labs has raised $39.9M.
-
Who are Peca Labs’s investors?
Runway Healthcare, Allegheny Financial Group, Warren Point Capital, Mountain State Capital, and Children's National are 5 of 10 investors who have invested in Peca Labs.
-
Who are Peca Labs’s competitors?
Xeltis, PUR Biologics, Corvivo, and Medtronic are competitors of Peca Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
